| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Jazz Pharmaceuticals Plc (JAZZ) has 19 insiders with recent SEC Form 4 filings, including 4 buys and 14 sells. JAZZ is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 1.18M | $265.78M | - | |
| Dir | 390.7K | $87.77M | - | |
| CEO | 152.2K | $34.19M | - | |
| VP | 72.6K | $16.32M | - | |
| CFO | 59.6K | $13.39M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 17, 2025 | Iannone Robert50 | EVP, Global Head Of R&D &CMO | Sell | 7,159 | $168.26 | $1,204,573.34 | -9.0% | -1.2% | - | |
| Oct 3, 2025 | Cozadd Bruce C59 | Director | Sell | 5,500 | $137.01 | $753,560.00 | -0.7% | +24.1% | - | |
| Sep 2, 2025 | Cozadd Bruce C59 | Director | Sell | 6,000 | $128.62 | $771,690.00 | -0.7% | +32.7% | - | |
| Aug 1, 2025 | Cozadd Bruce C59 | Chairman &CEO | Sell | 1,000 | $113.21 | $113,210.00 | -0.2% | +18.0% | - | |
| Jul 1, 2025 | Cozadd Bruce C59 | Chairman &CEO | Sell | 1,000 | $107.63 | $107,630.00 | -0.1% | +17.9% | - | |
| Jun 3, 2025 | Cozadd Bruce C59 | Chairman &CEO | Sell | 1,000 | $108.95 | $108,950.00 | -0.1% | +17.5% | +110.9% | |
| May 12, 2025 | Mulligan Seamus | Director | Buy | 101,621 | $98.34 | $9,993,081.71 | +36.2% | +6.9% | +120.0% | |
| May 2, 2025 | Cozadd Bruce C59 | Chairman &CEO | Sell | 1,500 | $117.57 | $176,350.00 | -0.2% | -4.5% | +68.9% | |
| Apr 1, 2025 | Cozadd Bruce C59 | Chairman &CEO | Sell | 1,500 | $123.75 | $185,625.00 | -0.3% | -15.1% | +50.6% | |
| Mar 10, 2025 | Iannone Robert50 | EVP, Global Head Of R&D &CMO | Sell | 2,403 | $138.41 | $332,604.52 | -2.9% | -18.6% | +35.3% |